Research Advances in the Structural Characterization and Biological Activity Assessment of Neocryptotanshinone

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Neocryptotanshinone (NCTS) is a rare diterpene quinone from Salvia miltiorrhiza, with its structure confirmed in 1987.
• Low natural abundance necessitates semisynthesis for obtaining NCTS.
• NCTS was identified as a nuclear factor kappa-B (NF-κB) pathway inhibitor in 2015.

Purpose of the Study:

• To review the current research progress on Neocryptotanshinone (NCTS) and its derivative.
• To cover structural characterization, synthesis, modifications, and pharmacological activities.
• To provide a reference for the future development of NCTS.

Main Methods:

• Literature review of studies on NCTS and its derivative, 16-Ooleoylneocryptotanshinone.
• Analysis of research on structural characterization, synthetic routes, and modifications.
• Evaluation of pharmacological activities, traditional Chinese medicine applications, and pharmacokinetics.

Main Results:

• NCTS exhibits low cytotoxicity and minimal cyclooxygenase-2 (COX-2) induction.
• It demonstrates therapeutic potential in conditions like heart failure, myocardial ischemia, cerebral ischemia, and type 2 diabetes mellitus.
• Pharmacokinetic studies are ongoing, with promising but unvalidated bioavailability and absorption kinetics.

Conclusions:

• NCTS possesses favorable pharmacological properties and modulates multiple therapeutic pathways.
• Its derivative, 16-Ooleoylneocryptotanshinone, is also under investigation.
• NCTS research is in its early stages, requiring further validation and development.